SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001993940-23-000001
Filing Date
2023-10-12
Accepted
2023-10-12 09:23:19
Documents
1
Effectiveness Date
2023-10-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4960
  Complete submission text file 0001993940-23-000001.txt   6076
Mailing Address C/O GAINGELS MANAGEMENT LLC 3 MAIN STREET - SUITE 214 BURLINGTON VT 05401
Business Address C/O GAINGELS MANAGEMENT LLC 3 MAIN STREET - SUITE 214 BURLINGTON VT 05401 2124047343
Gaingels GC Therapeutics LLC (Filer) CIK: 0001993940 (see all company filings)

IRS No.: 933376585 | State of Incorp.: VT | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-494515 | Film No.: 231321887